Yaron Werber
Stock Analyst at TD Cowen
(1.11)
# 3,684
Out of 4,944 analysts
37
Total ratings
34.62%
Success rate
-10.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines | Reiterates: Buy | $334 | $307.51 | +8.61% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $10.66 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $20.86 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $11.69 | - | 1 | Nov 19, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $160 → $153 | $191.15 | -19.96% | 5 | Nov 15, 2024 | |
| BNTX BioNTech SE | Maintains: Hold | $132 → $122 | $112.78 | +8.18% | 5 | Nov 6, 2024 | |
| UPB Upstream Bio | Initiates: Buy | n/a | $18.55 | - | 1 | Nov 5, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $61 → $73 | $28.97 | +151.98% | 2 | Oct 21, 2024 | |
| EXEL Exelixis | Maintains: Buy | $27 → $34 | $38.49 | -11.67% | 2 | Oct 21, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $54 → $59 | $43.10 | +36.89% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $36.93 | +81.42% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $16.91 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.97 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.22 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $24.99 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $612 → $641 | $646.60 | -0.87% | 3 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.61 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $375 → $625 | $9.88 | +6,225.91% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $26.97 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $22.67 | +67.62% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.31 | - | 1 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.96 | - | 1 | Oct 26, 2021 |
BeOne Medicines
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $307.51
Upside: +8.61%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $10.66
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $20.86
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $11.69
Upside: -
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $191.15
Upside: -19.96%
BioNTech SE
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $112.78
Upside: +8.18%
Upstream Bio
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $18.55
Upside: -
Ultragenyx Pharmaceutical
Oct 21, 2024
Maintains: Buy
Price Target: $61 → $73
Current: $28.97
Upside: +151.98%
Exelixis
Oct 21, 2024
Maintains: Buy
Price Target: $27 → $34
Current: $38.49
Upside: -11.67%
Ionis Pharmaceuticals
Jul 23, 2024
Maintains: Buy
Price Target: $54 → $59
Current: $43.10
Upside: +36.89%
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $36.93
Upside: +81.42%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $16.91
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $2.97
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $3.22
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $24.99
Upside: -
Dec 12, 2023
Maintains: Outperform
Price Target: $612 → $641
Current: $646.60
Upside: -0.87%
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $6.61
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $375 → $625
Current: $9.88
Upside: +6,225.91%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $26.97
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $22.67
Upside: +67.62%
Nov 30, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.31
Upside: -
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $11.96
Upside: -